Christian Weyer Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

Christian Weyer is EVP, Research & Development of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 27,341 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Apr 01, 2021, when has been sold 46 shares (Common Stock) at a price of $24.28 per share, resulting in proceeds of $1,117. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.3K

0% 3M change

0% 12M change

Total Value Held $0

Christian Weyer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2021	SELL Payment of exercise price or tax liability	$1,117 $24.28 p/Share	46 Reduced 0.17%	27,341 Common Stock
Feb 27 2021	SELL Payment of exercise price or tax liability	$7,733 $21.66 p/Share	357 Reduced 1.29%	27,387 Common Stock
Jan 22 2021	BUY Grant, award, or other acquisition	-	12,600 Added 31.23%	27,744 Common Stock
Jan 01 2021	SELL Payment of exercise price or tax liability	$1,334 $24.7 p/Share	54 Reduced 0.36%	15,144 Common Stock
Dec 31 2020	SELL Payment of exercise price or tax liability	$19,241 $24.7 p/Share	779 Reduced 4.88%	15,198 Common Stock
Nov 27 2020	SELL Payment of exercise price or tax liability	$13,305 $37.27 p/Share	357 Reduced 2.19%	15,977 Common Stock
Oct 01 2020	SELL Payment of exercise price or tax liability	$1,936 $42.08 p/Share	46 Reduced 0.28%	16,334 Common Stock

Christian Weyer

EVP, Research & Development

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Value

Insider Trading

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to INTERCEPT PHARMACEUTICALS, INC.

Account